Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Common side effects of ciprofloxacin when treating a urinary tract infection include nausea, diarrhea, headache, dizziness, and rash, while more serious risks involve tendon pain or rupture, nerve damage, mood or sleep changes, and, rarely, aortic problems. Certain people, including older adults and those taking steroids, face higher risks, and interactions with antacids, dairy, and other medications can change how the drug works. There are several important factors and warning signs to consider, all explained below.
If your symptoms are lingering, worsening, or you are unsure whether what you feel is the infection or a reaction to the antibiotic, a free, instant online symptom check can help you sort out likely causes in just a few minutes. It offers personalized, private guidance on how urgent your situation may be and which type of care to seek next, so you can act with confidence instead of guessing.
Last reviewed for medical accuracy: 09/24/2026
Side Effects of Ciprofloxacin for UTI
Ciprofloxacin is a commonly prescribed antibiotic for urinary tract infections (UTIs). It belongs to the fluoroquinolone class and works by stopping bacterial growth. While it can be very effective, it also carries a range of possible side effects. Understanding these can help you weigh the benefits against the risks, recognize any warning signs early, and know when to seek help.
Ciprofloxacin targets enzymes that bacteria need to replicate. This makes it a “bactericidal” antibiotic—it kills the bacteria rather than just slowing their growth. For uncomplicated UTIs, it’s often given as a 3- to 5-day course. For more complicated infections, treatment may last up to 14 days under close medical supervision.
Most people tolerate ciprofloxacin well, but nearly everyone feels something minor. These effects usually go away once you finish the medicine:
Tips to ease these symptoms:
Some side effects are less frequent yet worth knowing about:
If you notice any of these, inform your doctor. Simple measures—like wearing sunscreen and sturdy footwear—can help manage mild issues.
Though rare, certain reactions require immediate medical attention:
If you experience any of these, stop taking ciprofloxacin and seek emergency care.
Certain factors can raise the likelihood of side effects:
Your doctor will consider these before prescribing ciprofloxacin. If you fall into one of these categories, you may be offered an alternative antibiotic.
Most mild to moderate side effects can be managed with simple steps:
Always follow the dosage and duration prescribed. Stopping early can lead to bacterial resistance, making future infections harder to treat.
Even if symptoms seem minor, check in with your healthcare provider if you notice:
If you’re unsure about any symptom, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Reducing UTI recurrences can lower your need for antibiotics and their possible side effects:
Every antibiotic has pros and cons. Ciprofloxacin is powerful, with a broad spectrum against many UTI-causing bacteria. Yet, its potential for serious side effects means it’s often reserved for complicated or resistant cases. Your healthcare team will weigh factors such as:
Being informed about the side effects of ciprofloxacin for UTI helps you take an active role in your care. Most people finish their course without major issues, but knowing what to watch for ensures you can address any problems promptly. If you ever feel overwhelmed by side effects or are unsure whether they’re serious, don’t hesitate to seek medical advice. Your safety is the top priority.
Speak to a doctor about any side effect that feels life-threatening or particularly worrisome. They can adjust your treatment, suggest alternatives, or provide support to manage symptoms effectively.
(References)
* Terp DK, Rybak MJ. Ciprofloxacin. Drug Intell Clin Pharm. 1987 Jul-Aug;21(7-8):568-74. doi: 10.1177/1060028087021007-801. PMID: 3301247.
* Keam SJ, Perry CM. Prulifloxacin. Drugs. 2004;64(19):2221-34; discussion 2235-6. doi: 10.2165/00003495-200464190-00005. PMID: 15456336.
* Gluhovschi G, Gadalean F, Gluhovschi C, Velciov S, Petrica L, Bob F, Bozdog G, Kaycsa A. Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection? Biomed Pharmacother. 2016 Dec;84:366-372. doi: 10.1016/j.biopha.2016.09.052. Epub 2016 Sep 23. PMID: 27668536.
* Mumtaz K, Munir S, Muddassir M, Raza A, Waqas K, Shoaib Ahmed S, Malik A, Haider Naqvi SZ. Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections. Pak J Pharm Sci. 2021 May;34(3(Supplementary)):1111-1118. PMID: 34602440.
* Zhanel GG, Pozdirca M, Golden AR, Lawrence CK, Zelenitsky S, Berry L, Schweizer F, Bay D, Adam H, Zhanel MA, Lagacé-Wiens P, Walkty A, Irfan N, Naber K, Lynch JP 3rd, Karlowsky JA. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. PMID: 35294769.
* Bao W, Koro M, Loh GW, Ortiz A. Urinary Tract Infections in Long-term Care: Evaluation of Uropathogens, Antibiotic Susceptibility, and Empiric Treatment. Sr Care Pharm. 2022 Jun 1;37(6):232-243. doi: 10.4140/TCP.n.2022.232. PMID: 35610764.
* Dunne MW, Aronin SI, Das AF, Akinapelli K, Breen J, Zelasky MT, Puttagunta S. Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial. Clin Infect Dis. 2023 Jan 6;76(1):78-88. doi: 10.1093/cid/ciac704. PMID: 36068705; PMCID: PMC9825827.
* Dunne MW, Aronin SI, Das AF, Akinapelli K, Zelasky MT, Puttagunta S, Boucher HW. Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial. Clin Infect Dis. 2023 Jan 6;76(1):66-77. doi: 10.1093/cid/ciac738. PMID: 36069202; PMCID: PMC9825825.
* Valentine-King M, Zoorob R, Grigoryan L, Trautner B. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections. Ann Fam Med. 2022 Apr 1;20(20 Suppl 1). doi: 10.1370/afm.20.s1.3177. Epub 2022 Apr 1. PMID: 36944052; PMCID: PMC10549044.
* Hadidi MF, Alhamami N, Alhakami M, Abdulhamid AS, Alsharif A, Alomari MS, Alghamdi YA, Alshehri S, Ghaddaf AA, Alsenani FM, Almadani H. Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: a systematic review and network meta-analysis. World J Urol. 2024 Apr 8;42(1):221. doi: 10.1007/s00345-024-04922-5. Epub 2024 Apr 8. PMID: 38587648.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.